ACO Name and Location

Suburban Health ACO I
dba SHO ACO I, LLC
7509 NW Tiffany Springs Parkway
Suite 310
Kansas City, Missouri 64153

ACO Primary Contact

Primary Contact Name Desiree Brewer
Primary Contact Phone Number 916-542-4582
Primary Contact Email Address dbrewer@caravanhealth.com

Organizational Information

ACO participants:
ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Johnson Memorial Hospital Y
Hancock Regional Surgery Center, Llc N
Orthopaedic Care Center Under Johnson Memorial Hospital N
Family Physicians Of Johnson County N
Johnson County Womens Care Group N
Hancock Regional Hospital Y
Witham Memorial Hospital Y
Johnson Memorial Hospital Y
Hendricks County Hospital Y
Hendricks Regional Health Foundation Inc. N
David R. Wippermann Md Pc N
Hancock Physician Network, LLC N
 
 
ACO governing body:
Member Member’s Voting Power Membership Type ACO Participant TIN
Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Dillon Terry Member 1 Medicare Beneficiary Representative N/A
Speer Kevin Chairman 1 ACO Participant Representative Hendricks County Hospital
Heydon Larry Vice-Chairman 1 ACO Participant Representative Johnson Memorial Hospital
Ingham Raymond Secretary/ Treasurer 1 ACO Participant Representative Witham Memorial Hospital
Long Steve Member 1 ACO Participant Representative Hancock Regional Hospital
 
Key ACO clinical and administrative leadership:
Davis Lippincott ACO Executive
Thomas Cartwright Medical Director
LeeAnn Hastings Compliance Officer
Rayna Caplan Quality Assurance/Improvement Officer
 
Associated committees and committee leadership:
Committee Name Committee Leader Name and Position
Information Technology Committee Dan Leiter, Chairman
Care Coordination & Patient Engagement Committee Karen Farris-Barnhart, Chairman
Evidence-Based Medicine Committee Craig Wilson, M.D., Chairman
Finance Committee Keith Barnhart, Chairman
Quality & Performance Improvement Committee Craig Wilson, M.D., Chairman
 
Types of ACO participants, or combinations of participants, that formed the ACO:
  • ACO professionals in a group practice arrangement
  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Hospital employing ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses
  • First Agreement Period
    • Performance Year 2017, $0
    • Performance Year 2016, $0
    • Performance Year 2015, $3,598,062
Shared Savings Distribution
  • First Agreement Period
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion of distribution to ACO participants: 90%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion invested in infrastructure: 10%

Quality Performance Results

2017 Quality Performance Results:
ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 85.23 80.60
ACO-2 CAHPS: How Well Your Providers Communicate 94.09 93.13
ACO-3 CAHPS: Patients’ Rating of Provider 93.53 92.31
ACO-4 CAHPS: Access to Specialists 83.18 83.32
ACO-5 CAHPS: Health Promotion and Education 58.72 62.30
ACO-6 CAHPS: Shared Decision Making 75.53 75.85
ACO-7 CAHPS: Health Status/Functional Status 71.02 73.05
ACO-34 CAHPS: Stewardship of Patient Resources 33.17 25.68
ACO-8 Risk Standardized, All Condition Readmission 14.75 15.01
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 17.70 18.46
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 48.94 53.95
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 75.76 79.16
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 58.74 61.74
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 1.83 1.93
ACO-11 Use of Certified EHR Technology 100.00 98.48
ACO-12 Medication Reconciliation 99.41 75.32
ACO-13 Falls: Screening for Future Fall Risk 53.04 74.38
ACO-44 Imaging Studies for Low Back Pain 67.61 67.32
ACO-14 Preventive Care and Screening: Influenza Immunization 71.26 72.52
ACO-15 Pneumonia Vaccination Status for Older Adults 74.49 72.92
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 70.83 70.69
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 88.76 90.48
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 23.62 61.98
ACO-19 Colorectal Cancer Screening 69.41 64.58
ACO-20 Breast Cancer Screening 68.25 70.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 86.96 79.89
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 16.14 16.74
ACO-41 Diabetes: Eye Exam 34.25 50.37
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 67.39 71.47
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 87.95 86.86
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples. Note: In the Quality Performance Results file(s) above, search for “SHO ACO I, LLC” or “Suburban Health ACO” to view the quality performance results. This ACO can also be found by using the ACO ID A47336 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.
 
 
 

Public Disclosure Language for MSSP ACO Waivers

To avail itself of the Participation Waiver, Suburban Health ACO I (“Company ACO”) has made a good faith determination that the following arrangements are reasonably related to the purposes of the Medicare Shared Savings Program (MSSP) and is publically disclosing such arrangements in accordance with the requirements of the MSSP.
Provision of Medical Equipment. The Company ACO is currently participating in the MSSP as an accountable care organization (“ACO”). In connection with its ACO activities, Company ACO or one or more of its ACO participant(s) (as identified on this website) including such participant’s providers, will provide to patients, free or below fair market value, medical equipment that the Company ACO or ACO participant or provider reasonably determines is necessary or useful for the patient to fully engage in preventive care, or to adhere to his/her treatment, drug or follow-up care regimes or to manage his/her chronic disease or condition. This arrangement was approved by the board of the Company ACO on July 16, 2015 and is expected to be effect in until December 31, 2018.
Provision of Delivery Services and Medication. The Company ACO is currently participating in the MSSP as an accountable care organization (“ACO”). In connection with its ACO activities, Company ACO or one or more of its ACO participant(s) (as identified on this website) including such participant’s providers, will provide to patients, (i) free or discounted (including, below fair market value) delivery of medications; or (ii) free medications to patients with demonstrated financial need. The provision of (i) free or discounted (including, below fair market value) delivery of medications, and of (ii) free medications to patients with demonstrated financial need, by the Company ACO, or by a Company ACO participant or provider, is necessary or useful for the patient to fully engage in preventive care, or to adhere to his/her treatment, drug or follow-up care regimes or to manage his/her chronic disease or condition. This arrangement was approved by the board of the Company ACO on July 16, 2015 and is expected to be in effect until December 31, 2018.
Transportation Services. The Company ACO is currently participating in the MSSP as an accountable care organization (“ACO”). In connection with its ACO activities, Company ACO or one or more of its ACO participant(s) (as identified on this website) including such participant’s providers, will provide to patients affordable transportation options, which includes the provision of shuttle services or a coupon or voucher that patients can use to purchase transportation services from a transportation vendor, in order to ensure patients are able to keep appointments with primary care providers, and obtain necessary medications and other necessary medical services all of which advance one or more of the following clinical goals: (a) adherence to a treatment regime; (b) adherence to a drug regime; (c) adherence to a follow-up care plan; or (d) management of a chronic disease or condition. This arrangement was approved by the board of the Company ACO on April 16, 2015 and is expected to be in effect until December 31, 2018.
Pre-Participation Waiver. To avail itself of the Participation Waiver, the Company ACO has made a good faith determination that the following arrangements are reasonably related to the purposes of the MSSP, has undertaken such arrangements with the good faith intention of developing an ACO that will participate in the MSSP, and is publically disclosing such arrangements in accordance with the requirements of the MSSP.
  • Participation Agreements. The Company’s ACO Board of Managers (“Board”) has reviewed and approved certain participation agreements (“Participation Agreements”). The Company ACO entered into Participation Agreements with each participant (“ACO Participant”). Under the Participation Agreements, the Company ACO (directly or through the NSC and other vendors) provided to ACO Participants the overall administrative, management and information technology support necessary to operate the ACO, including implementation of evidence-based medical practice and clinical guidelines, promotion of patient engagement, and procedures for managing the quality, safety, and cost of services provided to Medicare beneficiaries, in exchange for the ACO Participant’s participation in the ACO, in-kind services, and the use of AIM funding. The Participation Agreements encourage ACO Participants to provide clinical services to patients in order to promote improved quality of care under various quality assurance initiatives undertaken by the ACO, improve patient satisfaction, and help reduce the cost of providing quality health care, all in furtherance of the purposes of the MSSP. The Participation Agreement provides for a remediation process and describes how shared savings will be distributed. The Participation Agreement was signed prior to the MSSP application deadline. The ACO Participants who are parties to the Participation Agreement are identified on this website.
  • ACO Services Agreement. The Company ACO, directly, and through Caravan Health f/k/a/ NRACO Services Corporation (“NSC”) engaged in activities related to the formation of the Company ACO’s legal entity, the drafting of the corporate and participation documents, the development and submission of the Company ACO’s applications for participation in the MSSP and for AIM funding, the recruitment and contracting of the Company ACO participants and providers, the development and purchase of a data warehouse and information technology infrastructure, acquiring the staff and infrastructure necessary to successfully participate in the MSSP, and the funding of all of the above activities. The start-up arrangement began May 2015 with the formation of the ACO.
Participation Waiver. To avail itself of the Participation Waiver, the Company ACO has made a good faith determination that the following arrangements are reasonably related to the purposes of the Medicare Shared Savings Program (MSSP) and is publically disclosing such arrangements in accordance with the requirements of the MSSP.
  • ACO Services Agreement. The Company ACO, directly, or through NSC and other vendors, engages in activities related to the drafting of the participation and related documents, the recruitment and contracting of the Company ACO participants and providers, the purchase and implementation of a data warehouse and information technology infrastructure, acquiring the staff and infrastructure necessary to successfully participate in the MSSP, and the funding of all of the above activities. The services agreement was in effect on or before January 1, 2016.
  • Participation Agreements. The Company ACO entered into Participation Agreements with each ACO Participant. Under the Participation Agreements, the Company ACO (directly or through NSC and other vendors), provides to ACO Participants the overall administrative, management and information technology support necessary to operate the ACO, including implementation of evidence-based medical practice and clinical guidelines, promotion of patient engagement, and procedures for managing the quality, safety, and cost of services provided to Medicare beneficiaries, in exchange for the ACO Participant’s participation in the ACO, in-kind services, and the use of AIM funding. The Participation Agreements encourage ACO Participants to provide clinical services to patients in order to promote improved quality of care under various quality assurance initiatives undertaken by the ACO, improve patient satisfaction, and help reduce the cost of providing quality health care, all in furtherance of the purposes of the MSSP. The Participation Agreement provides for a remediation process and describes how shared savings will be distributed. The ACO Participants who are parties to the Participation Agreement are identified on this website. The Participation Agreement was signed prior to the MSSP application deadline, or prior to the participant joining the Company ACO.
For general questions or additional information about Accountable Care Organizations, please visit medicare.gov or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048.